Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
52 hedge funds and large institutions have $14.4M invested in Histogen Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 16 closing their positions.
74% more call options, than puts
Call options by funds: $1.95M | Put options by funds: $1.12M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
5% less funds holding
Funds holding: 55 → 52 (-3)
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
74% less capital invested
Capital invested by funds: $56M → $14.4M (-$41.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$859K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$735K |
| 3 |
HP
Hikari Power
Tokyo,
Japan
|
+$650K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$406K |
| 5 |
Parallax Volatility Advisers
San Francisco,
California
|
+$401K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3M |
| 2 |
AG
Artal Group
Luxembourg
|
-$2.9M |
| 3 |
Axa
Paris,
France
|
-$2.57M |
| 4 |
Millennium Management
New York
|
-$782K |
| 5 |
Goldman Sachs
New York
|
-$414K |
HSTO Hedge Fund Activity: Q4 2018 in Review
52 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q4 2018, worth a combined $14.4M — down 74% from $56M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of HSTO and 13 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 14 added.
The largest buyer was Two Sigma Investments, adding an estimated $859K. The largest seller was Vanguard Group, cutting an estimated $3M.
- 52 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q4 2018, down from 55 in Q3 2018.
- Funds reported $14.4M of Histogen Inc. Common Stock stock for Q4 2018, down 74% quarter-over-quarter.
- 13 funds opened new Histogen Inc. Common Stock positions in Q4 2018 and 16 closed out, a net change of -3 holders.
- The largest Histogen Inc. Common Stock buyer in Q4 2018 was Two Sigma Investments, an estimated $859K added.
- The largest Histogen Inc. Common Stock seller in Q4 2018 was Vanguard Group, an estimated $3M sold.
Based on aggregated 13F filings for Q4 2018.